Who owns Arbutus Biopharma?
- Ticker: ABUS
- CUSIP Number: 03879j100
Tip: Access positions for across all investors
Analyze quarterly positions in Arbutus Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arbutus Biopharma stock
Who bought or sold Arbutus Biopharma this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Whitefort Capital Management | 13M | $33M | -3% | Mar 2024 |
|
| BlackRock | 10M | $27M | 1% | Mar 2024 |
|
| Morgan Stanley | 8.8M | $23M | 68% | Mar 2024 |
|
| Two Seas Capital | 7.8M | $20M | -5% | Mar 2024 |
|
| Vanguard Group | 6.0M | $15M | 0% | Mar 2024 |
|
| FourWorld Capital Management | 4.6M | $12M | 319% | Mar 2024 |
|
| Woodline Partners | 4.1M | $11M | -14% | Mar 2024 |
|
| Hudson Bay Capital Management | 3.5M | $9.1M | -15% | Mar 2024 |
|
| Adage Capital Partners GP | 3.0M | $7.7M | 100% | Mar 2024 |
|
| Geode Capital Management | 3.0M | $7.6M | 10% | Mar 2024 |
|
| Citadel Advisors | 2.2M | $5.7M | 6% | Mar 2024 |
|
| ADAR1 Capital Management | 2.1M | $5.4M | -43% | Mar 2024 |
|
| BlackBarn Capital Partners | 2.1M | $5.3M | 100% | Mar 2024 |
|
| Centiva Capital | 1.6M | $4.2M | -24% | Mar 2024 |
|
| Squarepoint Ops | 1.4M | $3.7M | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.4M | $3.5M | 0% | Mar 2024 |
|
| Susquehanna International | 1.3M | $3.3M | 243% | Mar 2024 |
|
| Northern Trust | 1.1M | $2.7M | -1% | Mar 2024 |
|
| Citigroup | 697k | $1.8M | -21% | Mar 2024 |
|
| Boothbay Fund Management | 612k | $1.6M | 25% | Mar 2024 |
|
| Kennedy Capital Management | 437k | $1.1M | 13% | Mar 2024 |
|
| Bank of New York Mellon | 408k | $1.1M | -11% | Mar 2024 |
|
| Saba Capital Management | 374k | $964k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 349k | $902k | 20% | Mar 2024 |
|
| Charles Schwab Investment Management | 339k | $875k | -3% | Mar 2024 |
|
| Bank Of Montreal | 334k | $872k | -5% | Mar 2024 |
|
| Nuveen Asset Management | 294k | $759k | 1% | Mar 2024 |
|
| Millennium Management | 242k | $625k | -84% | Mar 2024 |
|
| Goldman Sachs Group | 175k | $451k | 38% | Mar 2024 |
|
| Rhumbline Advisers | 171k | $440k | 4% | Mar 2024 |
|
| FMR | 166k | $428k | -6% | Mar 2024 |
|
| LMR Partners | 160k | $413k | 167% | Mar 2024 |
|
| UBS Group | 135k | $348k | -4% | Mar 2024 |
|
| American Century Companies | 126k | $326k | 610% | Mar 2024 |
|
| Clear Harbor Asset Management | 116k | $300k | -17% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 103k | $266k | 100% | Mar 2024 |
|
| Lighthouse Investment Partners | 99k | $256k | 100% | Mar 2024 |
|
| Two Sigma Investments | 98k | $253k | -52% | Mar 2024 |
|
| Alliancebernstein | 96k | $240k | 5% | Dec 2023 |
|
| Barclays | 89k | $230k | -76% | Mar 2024 |
|
| Jpmorgan Chase & Co | 88k | $227k | -24% | Mar 2024 |
|
| Simplex Trading | 88k | $227k | -16% | Mar 2024 |
|
| Royal Bank of Canada | 73k | $191k | -32% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 73k | $188k | 9% | Mar 2024 |
|
| Bank of America Corporation | 69k | $177k | -26% | Mar 2024 |
|
| Group One Trading | 66k | $170k | 100% | Mar 2024 |
|
| American International | 63k | $157k | 1% | Dec 2023 |
|
| MetLife Investment Advisors | 59k | $148k | 0% | Dec 2023 |
|
| Gts Securities | 50k | $129k | 3% | Mar 2024 |
|
| Cowen And Company | 50k | $129k | 0% | Mar 2024 |
|
| Ing Investment Management | 45k | $116k | -68% | Mar 2024 |
|
| New York State Common Retirement Fund | 44k | $114k | -1% | Mar 2024 |
|
| Jane Street | 44k | $114k | -54% | Mar 2024 |
|
| Toroso Investments | 43k | $111k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 43k | $111k | 14% | Mar 2024 |
|
| Verus Capital Partners | 42k | $108k | 30% | Mar 2024 |
|
| Principal Financial Group | 41k | $107k | -9% | Mar 2024 |
|
| T. Rowe Price Associates | 36k | $94k | 22% | Mar 2024 |
|
| Caption Management | 35k | $90k | -92% | Mar 2024 |
|
| ProShare Advisors | 35k | $89k | 27% | Mar 2024 |
|
| China Universal Asset Management | 32k | $83k | 66% | Mar 2024 |
|
| Premier Path Wealth Partners | 31k | $79k | 37% | Mar 2024 |
|
| Creative Planning | 30k | $77k | 105% | Mar 2024 |
|
| Scotia Capital | 29k | $73k | 0% | Dec 2023 |
|
| Moneta Group Investment Advisors | 25k | $63k | 9% | Dec 2023 |
|
| Kades & Cheifetz | 20k | $52k | 0% | Mar 2024 |
|
| SG Americas Securities | 20k | $51k | -57% | Mar 2024 |
|
| PFG Investments | 19k | $50k | 100% | Mar 2024 |
|
| Virtu Financial | 18k | $45k | 100% | Dec 2023 |
|
| Buckingham Asset Management | 18k | $46k | 0% | Mar 2024 |
|
| Two Sigma Advisers | 18k | $45k | -43% | Mar 2024 |
|
| Walleye Trading | 14k | $36k | 100% | Mar 2024 |
|
| First Manhattan | 14k | $36k | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 13k | $34k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 13k | $33k | -54% | Mar 2024 |
|
| WMG Financial Advisors | 13k | $33k | 0% | Mar 2024 |
|
| Legal & General Group | 12k | $32k | 0% | Mar 2024 |
|
| Front Row Advisors | 11k | $27k | 0% | Mar 2024 |
|
| Brevan Howard Capital Management | 11k | $27k | -41% | Mar 2024 |
|
| Pathstone Holdings | 10k | $26k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 9.1k | $24k | 0% | Mar 2024 |
|
| Farther Finance Advisors | 8.0k | $21k | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 6.9k | $18k | 100% | Mar 2024 |
|
| Dynamic Wealth Strategies | 6.3k | $16k | 100% | Mar 2024 |
|
| Atlantic Trust | 5.5k | $14k | 100% | Mar 2024 |
|
| Cambridge Trust Company | 5.0k | $13k | 0% | Dec 2023 |
|
| Steward Partners Investment Advisory | 4.0k | $10k | 0% | Mar 2024 |
|
| NISA Investment Advisors | 3.8k | $9.9k | 0% | Mar 2024 |
|
| Amalgamated Bank | 3.8k | $10k | -74% | Mar 2024 |
|
| Financial Synergies Wealth Advisors | 3.6k | $9.3k | -51% | Mar 2024 |
|
| Russell Investments | 3.1k | $8.1k | 39% | Mar 2024 |
|
| Signature | 3.0k | $7.8k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 3.0k | $7.4k | -52% | Dec 2023 |
|
| Tower Research Capital | 1.9k | $4.8k | -80% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 1.8k | $4.7k | 0% | Dec 2023 |
|
| CWM | 1.7k | $4.0k | 1087% | Mar 2024 |
|
| Us Bancorp | 1.5k | $3.7k | 100% | Mar 2024 |
|
| Benjamin F. Edwards & Company | 1.1k | $3.0k | 0% | Mar 2024 |
|
| Quadrant Capital | 878.00 | $2.3k | 217% | Mar 2024 |
|
| Harbor Investment Advisory | 803.00 | $2.1k | 0% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 800.00 | $2.1k | 100% | Mar 2024 |
|
| Cornerstone Planning Group | 782.00 | $2.1k | 100% | Mar 2024 |
|
| Parallel Advisors | 550.00 | $1.4k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 395.00 | $999.982000 | 0% | Mar 2024 |
|
| Lindbrook Capital | 284.00 | $733.004000 | 0% | Mar 2024 |
|
| Private Wealth Management Group | 242.00 | $624.989200 | 0% | Mar 2024 |
|
| Pnc Financial Services | 208.00 | $536.993600 | 0% | Mar 2024 |
|
| GAMMA Investing | 187.00 | $481.992500 | 0% | Mar 2024 |
|
| Covestor | 67.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 24.00 | $61.000800 | 100% | Mar 2024 |
|
Who sold out of Arbutus Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Assenagon Asset Management | Dec 2023 | 818k | $2.0M |
| Tejara Capital | Dec 2023 | 180k | $450k |
| Point72 Asset Management | Dec 2023 | 105k | $263k |
| Ameriprise Financial | Sep 2023 | 98k | $199k |
| Florida State Board of Administration | Dec 2023 | 36k | $90k |
| Arete Wealth Advisors | Dec 2023 | 15k | $38k |
| Qube Research & Technologies | Sep 2023 | 8.2k | $17k |
| Cubist Systematic Strategies | Dec 2023 | 7.2k | $18k |
| Dagco | Dec 2023 | 6.3k | $16k |
| Cutler | Dec 2023 | 4.5k | $11k |
| Blue Bell Private Wealth Management | Dec 2023 | 500.00 | $1.3k |